An emerging body of evidence indicates that NF-κB and STAT3 have been identified as active participants in colon cancer progression and the inhibition of the activation of these two proteins has the potential to prevent and treat colon cancer [25]. This evidence concerns the gene NFKB1 and malignant colon neoplasm.